180 likes | 219 Views
Clinical case. Blanca Gonzalez- Farre , I.Salaverria , D.Costa , CM Panizo, C. Lopez, R. Siebert, E. Campo. Clinical course. Consultation case 17 years-old female Caucasian Submandibular LN.
E N D
Clinical case Blanca Gonzalez-Farre, I.Salaverria, D.Costa, CM Panizo, C. Lopez, R. Siebert, E. Campo
Clinical course • Consultation case • 17 years-old female • Caucasian • Submandibular LN
Effacement of the normal architecture by an atypical lymphoid proliferation with a “starry sky” pattern
Medium sized cells with finely clumped chromatin. Highly proliferative tumor
CD20 CD5 CD3
CD10 BCL6 Ki67 BCL2
MYC TdT EBER
Genetic studies • FISH studies done in Barcelona • FISH LSI MYC BAP: No rearrangement. 3 copies of MYC in 35% of cells studied. • FISH studies done in Kiel • FISH LSI IGH: No break • FISH LSI BCL6: No break • FISH LSI BCL2 : No break • IGH-MYC dual color dual fusion: No fusion • 11qBL probe (not commercial): extra copies (2-5) for the green signal • Copy number profile using Affymetrix SNP 6 array: 14 regions of copy number aberration (7 gains, 1 amplification and 7 losses) and one region of copy neutral loss of heterozygosity (CN-LOH)
MYC BAP No breaks, 3 copies of MYC in 35% of cells studied
BCL2 BAP 2 copies for BCL2, no breaks
Copy number aberrations and loss of heterozygosity* • 14 regions of copy number aberration (6 gains, 1 amplification and 7 losses) and one region of copy neutral loss of heterozygosity (CN-LOH). *Build = NCBI Build 37
Copy number (CN) and CN-LOH aberrations* CN profile +3q24-q29 +11q14.1 - q23.3 +12q11-q22 +18q12.1-q21.32 -6q12-q27 -18q213-q23 Allelic ratio Gain Loss CN-LOH 11q23.3-q25 * Only large regions alteration (>15MB) are labelled with arrows
Amplif 11q23.3 chr11 +11q14.1 - q23.3 CN-LOH 11q23.3-q25 Gain CN-LOH
Verification of 11q aberration by FISH CEP11 RP11-414621 RP11-629A20 (ETS1 gene) 2 copies for the centromer (blue signal), 2 copies for ETS1 (red signal), and 2-5 copies for RP11-414G21 (green signal)
Summary • High grade B-cell lymphoma with peculiar morphological and immunophenotypical features • Morphologically Burkitt lymphoma with some and scattered larger cells • Absence of MYC translocation • Absence of other primary translocations (negative for breaks of BCL2, BCL6, IGH) • Presence of chr11 aberrations previously associated to MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma, with the peculiarity that the described 11q loss is in this case a strength of CN-LOH that could be selecting potential mutations in tumor suppressor genes in this region (for example ETS1). • Final Diagnosis: Burkitt-like lymphoma with 11q alterations